Also, that VprBP knockdown and B32B3 treatment were well tolerated without any significant changes in body weight (Additional file 10: Fig. S10) argues strongly that their inhibitory effects are generated by specifically targeting G361 melanoma cells in mice. Here, DCAF1 is linked to melanoma.